Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 5/20 | 0.49 |
| ▸ | MAPK8 | P45983 | 13/20 | 0.33 |
| ▸ | MAPK10 | P53779 | 11/20 | 0.33 |
| ▸ | MAPK9 | P45984 | 10/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22200592 | 0.92 | ERN1 (0.55) | ERN1MAPK8MAPK10MAPK9MAPK14 | |
| SCHEMBL22200742 | 0.89 | ERN1 (0.49) | ERN1MAPK8MAPK10MAPK9MEN1 | |
| SCHEMBL22200599 | 0.89 | ERN1 (0.51) | ERN1MAPK8MAPK10MAPK9MAPK14 | |
| SCHEMBL22190893 | 0.88 | ERN1 (0.57) | ERN1MAPK8MAPK10MAPK9MAPK14 | |
| SCHEMBL22200381 | 0.88 | ERN1 (0.47) | ERN1MAPK8MAPK10MAPK9MAPK14 | |
| SCHEMBL29357971 | 0.88 | ERN1 (0.57) | ERN1MAPK8MAPK10MAPK9MAPK14 | |
| SCHEMBL22200675 | 0.88 | ERN1 (0.57) | ERN1MAPK8MAPK10MAPK9MAPK14 | |
| SCHEMBL22200676 | 0.88 | ERN1 (0.57) | ERN1MAPK8MAPK10MAPK9MAPK14 | |
| Hydrochloric Acid SCHEMBL22191423 | 0.87 | ERN1 (0.57) | ERN1MAPK8MAPK10MAPK9MAPK14 | |
| Hydrochloric Acid SCHEMBL29354734 | 0.87 | ERN1 (0.57) | ERN1MAPK8MAPK10MAPK9MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020142612-A1 | PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. | GENENTECH, INC. (US) | 2020-07-09 | — | — | WO | disclosed |